InspireMD

InspireMD is a privately owned development stage medical device company. The company, which was established in 2005, has its focus on the development of stents for interventional cardiology market.

InspireMD main product is the MGuard, a combination of a stent and an embolic protection device. The embolic protection device is comprised of an ultra-thin polymer mesh protective sleeve, wrapped around the stent.

In October 2007 the MGuard Coronary received CE Mark for treatment of coronary arterial disease and the company began shipping its product to customers in Europe, Asia and Latin America. InspireMD is in the process of applying its stent design to the treatment of cerebral aneurysms.